Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ziff Asset Management is a private investment firm and family office that manages the capital of the Ziff family, heirs to the Ziff Davis publishing fortune. Based in New York, the firm is a prominent institutional investor within the life sciences and biotechnology sectors, providing venture capital and growth equity to innovative healthcare companies. While Ziff Asset Management does not develop its own therapeutic products or maintain a clinical pipeline, it acts as a key financial stakeholder in the biotech ecosystem. The firm is an affiliate of Ziff Brothers Investments, which was historically one of the largest and most successful family offices in the United States. Its investment portfolio has included significant positions in genomics, molecular diagnostics, and biopharmaceutical companies, supporting the development of cutting-edge medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziff Asset Management.